43 results
10-K
2021 FY
EX-4.19
SRNEQ
Sorrento Therapeutics, Inc.
Annual report
11 Mar 22
5:17pm
S-3ASR
EX-4.21
SRNEQ
Sorrento Therapeutics, Inc.
23 Dec 21
Automatic shelf registration
5:20pm
S-3
EX-4.18
SRNEQ
Sorrento Therapeutics, Inc.
Shelf registration
9 Apr 21
5:05pm
S-3
EX-4.19
SRNEQ
Sorrento Therapeutics, Inc.
Shelf registration
9 Apr 21
5:05pm
10-K
2020 FY
EX-4.18
SRNEQ
Sorrento Therapeutics, Inc.
Annual report
19 Feb 21
5:23pm
8-K
EX-4.1
637gf3
11 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
jt8ksx5uhnchtpygc2k
9 Dec 19
SORRENTO Announces new board member
7:00am
8-K
EX-4.2
tm6zbsgi
9 Dec 19
SORRENTO Announces new board member
7:00am
8-K
EX-4.1
jsmgyyz 23fkic7xkr
8 Oct 19
Sorrento Therapeutics Announces $25 Million Registered Direct Offering
4:18pm
8-K
EX-4.1
qkn63r11
28 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-4.2
6b8hwda6nkdt4m
28 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-4.3
1eorxrhrso
28 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-4.1
c5vjhpwe0r qs1e
3 May 19
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.2
bri rrv8h2crl4
3 May 19
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.2
lbsnu3zu9xq4ppazoz8
14 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
jrev297 l4
14 Jun 18
Entry into a Material Definitive Agreement
12:00am